Viral sequencing is the process of reading and characterizing the genome of viruses in clinical samples. In this testimony, Teresa Cutino Moguel shares her insights into the importance of viral sequencing, the challenges faced, and the role of technology in advancing this field. She also emphasizes the importance of accessibility and representation in science.
Viral sequencing has evolved from being a research tool to an essential instrument for clinicians. It has been used for years to test for antiviral resistance, but the pandemic has highlighted its direct applicability in patient management. It has become a tool that clinicians are increasingly aware of, especially during the waves caused by different COVID-19 variants.
Teresa emphasizes that everyone, regardless of gender or resources, has the potential to contribute to science. She also highlights the importance of role models for younger women, stressing the need for representation in the field.
Teresa's team is working on various projects, focusing on developing and growing sequencing capability for diagnostic purposes and understanding pathology. Collaborations have been made possible thanks to the pandemic, allowing connections with colleagues in universities and other areas.
The technology that brings knowledge and benefits to everyone must be accessible to all. Teresa stresses the need for this technology to reach all corners of the world, allowing contributions from capable and motivated individuals everywhere.
Teresa Cutino Moguel's testimony provides valuable insights into the world of viral sequencing and the role of technology in advancing this field. Her emphasis on accessibility, representation, and collaboration paints a picture of a future where science is inclusive and reaches every part of the globe. Her work with MGI-Tech equipment showcases the potential of modern technology in transforming healthcare and research.